All terms in NCIT
| Label | Id | Description |
|---|---|---|
| 14q | NCIT_C13538 | [Distal (long) arm of chromosome 14] |
| Stressor | NCIT_C54571 | [An agent, stimulus, activity, or event that causes stress on an organism, speeds up a reaction rate, or keeps a reaction rate the same.] |
| Split | NCIT_C54572 | [To separate or divide into distinct parts or portions.] |
| Passage | NCIT_C54573 | [Removal of a cell culture from the culture vessel with a subculture (passage) process, in order to keep the cells at a sufficiently low density to stimulate further growth.] |
| Tissue Culture | NCIT_C17201 | [Originally the maintenance and growth of pieces of explanted tissue (plant or animal) in culture away from the source organism. Now usually refers to the (much more frequently used) technique of cell culture, using cells dispersed from tissues or distant descendants of such cells.] |
| Double | NCIT_C54574 | [A twofold increase.] |
| Blister Dosing Unit | NCIT_C54564 | [A dosing unit equal to the amount of active ingredient(s) contained in a blister.] |
| Preserved Nuclear Polarity | NCIT_C54565 | |
| Fourth | NCIT_C54566 | [Following the third position in an ordering or series; coming next after the third and just before the fifth in position.] |
| Ordinal Position | NCIT_C46126 | [A number designating a place in an ordered sequence.] |
| Fifth | NCIT_C54567 | [Following the fourth position in an ordering or series; coming next after the fourth and just before the sixth in position.] |
| Sixth | NCIT_C54568 | [Following the fifth position in an ordering or series; coming next after the fifth and just before the seventh in position.] |
| Normalized Quotient | NCIT_C54569 | [Following amplification of reverse transcriptase polymerase chain reaction assay, the quantified amount of the target gene divided by the quantified amount of housekeeping gene.] |
| DNA Analysis | NCIT_C17632 | [Any DNA based laboratory tests.] |
| Type Of Manufacturer | NCIT_C54597 | |
| Type of Manufacturer ICSR Terminology | NCIT_C54598 | [Terminology used in Individual Case Safety Reports to specify a type of medical product manufacturer.] |
| SPL Limitation of Use Terminology | NCIT_C54599 | [Terminology used for representation of information on factors that could limit use of medical product for a specific indication in the framework of the Structured Product Labeling documentation.] |
| Location of Event Occurrence ICSR Terminology | NCIT_C54590 | [Terminology used in Individual Case Safety Reports to specify information on a location where an event occurred, section F12 of FDA MedWatch Form.] |
| Type of Reportable Event ICSR Terminology | NCIT_C54591 | [Terminology used in Individual Case Safety Reports to specify the type of reportable event, section H1 of FDA MedWatch Form.] |
| Type of Follow-Up ICSR Terminology | NCIT_C54592 | [Terminology used in Individual Case Safety Reports to specify a type of follow-up after an initial report has been submitted, section H2 of FDA MedWatch Form.] |